Several mechanistic investigations have shown that NEUROD1 effectors boost the survival, migration, and proliferation of small-cell lung cancer (SCLC) cells by activating cell surface receptor tyrosine kinase tropomyosin-related kinase B (TRKB) and neural cell adhesion factor (NCAM1). This evidence concerns the gene NTRK2 and small cell lung carcinoma.